Yayınlar & Eserler

Yayın Ağı
Makaleler 18
Tümü (18)
SCI-E, SSCI, AHCI (16)
SCI-E, SSCI, AHCI, ESCI (18)
ESCI (2)
Scopus (17)
TRDizin (1)

1. Predictive value of the 68Ga-PSMA-11 PET/CT PRIMARY score for pathological upgrading in patients with ISUP Grade 1 prostate cancer and PSA < 20 ng/mL undergoing radical prostatectomy

Ciftci E., AKOVALI B., Gumusgoz H. S., Erkek B. K.
Annals of Nuclear Medicine , cilt.40, sa.7, ss.746-753, 2026 (SCI-Expanded, Scopus) Creative Commons License

2. May it be a new parameter of [18F]FDG PET/CT for differentiating between benign and malignant adrenal lesions: “Adrenal Densitometabolic Index (ADMI)” Evaluación de un nuevo parámetro de la PET/TC con [18F]FDG para diferenciar entre lesiones suprarrenales benignas y malignas: el «índice densitometabólico suprarrenal (IDMS)»

Ciftci E., Erdil T., Erkek B., AKOVALI B.
Revista Espanola de Medicina Nuclear e Imagen Molecular , cilt.45, sa.4, 2026 (SCI-Expanded, Scopus)

3. Investigating the FIB-4 index and PET/CT metabolic parameters for the differentiation status of hepatocellular carcinoma

Ciftci E., Gulbagci B., Gumusgoz H. S., AKOVALI B., Erkek B. K.
ANNALS OF CLINICAL AND ANALYTICAL MEDICINE , cilt.17, ss.167-171, 2026 (ESCI) Creative Commons License

4. Why so many doses, and why now?

BİLGİÇ S., AKOVALI B.
European Thyroid Journal , cilt.14, 2025 (SCI-Expanded, Scopus)

5. THE RELATIONSHIP BETWEEN TUMOR MEAN STANDARD UPTAKE VALUE (SUVMAX) IN PREOPERATIVE PET/COMPUTED TOMOGRAPHY AND PROGNOSTIC RISK GROUPS IN ENDOMETRIAL CANCER

Bese T. T., Bicer E., Kosuk A. T., AKOVALI B., Turan H., Kabasakal L., et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , cilt.33, 2023 (SCI-Expanded, Scopus)

6. The relationship between tumor mean standard uptake value (SUVmax) in preoperative PET/computed tomography and prognostic risk groups in endometrial cancer

Bese T., Bicer E., Kosuk A. T., AKOVALI B., Turan H., Kabasakal L., et al.
NUCLEAR MEDICINE COMMUNICATIONS , cilt.44, sa.3, ss.204-211, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Breast cancer to thyroid gland: An unconventional metastatic site

Celik E., Ozturk T., Samanci N. S., DEMİRCİ N. S., AKOVALI B., Demirelli F. H.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.18, sa.3, ss.788-791, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Investigation of 18F-FDG PET/CT Findings and CA-125 Levels in Ovarian Cancer Staging

Akyel R., Akgun E., AKOVALI B., ŞAHİN O. E., SAĞER M. S., AÇIKGÖZ A. S., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.37, sa.2, ss.174-181, 2022 (ESCI, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

9. Complete response after ceritinib treatment in non-small cell lung cancer in an elderly patient

Sengul Samanci N., Celik E., AKOVALI B., SAĞER M. S., Demirelli F. H.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.8, ss.2031-2033, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. The impact of different computational assumptions in131I dosimetry for hyperthyroidism therapy

Abuqbeitah M., SAĞER M. S., DEMİR M., YEYİN N., AKOVALI B., SÖNMEZOĞLU K.
MEDICAL PHYSICS , cilt.47, sa.11, ss.5810-5816, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. Hyperprogression after nivolumab for melanoma: A case report

Yilmaz M., AKOVALI B.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.1, ss.244-251, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma

SAĞER M. S., Akgun E., USLU BEŞLİ R. L., ASA S., AKOVALI B., ŞAHİN O. E., et al.
NUCLEAR MEDICINE COMMUNICATIONS , cilt.40, sa.5, ss.461-468, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. The Importance Of Ga-68 PSMA PET CT In Detection Of Recurrence Metastasis Prostate Cancer Without Biochemical Recurrence

AKGÜN E., ŞAHİN O. E., Demirci E., AKOVALI B., DEMİRCİ M., AYGÜN A., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.44, 2017 (SCI-Expanded, Scopus)

14. Comparison of Therapy Response Between PERCIST and RECIST Criteria After Yttrium-90 Therapy in HCC Patients

SAĞER M. S., Akgun E., USLU BEŞLİ R. L., Asa S., ŞAHİN O. E., AKOVALI B., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.44, 2017 (SCI-Expanded, Scopus)

15. Efficacy and Safety of 177Lu-PSMA-617 Treatment in Castration Resistant Prostate Cancer with Organ Metastasis

ŞAHİN O. E., Akgun E., Demirci E., Ocak M., Akgun A., AKOVALI B., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.44, 2017 (SCI-Expanded, Scopus)

16. Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging

Demirci E., ŞAHİN O. E., Ocak M., AKOVALI B., Nematyazar J., KABASAKAL L.
NUCLEAR MEDICINE COMMUNICATIONS , cilt.37, sa.11, ss.1169-1179, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. Normal Distribution Pattern and Physiological Variants of Ga-68-PSMA PET/CT

Demirci E., ŞAHİN O. E., Ocak M., AKOVALI B., KABASAKAL L.
JOURNAL OF NUCLEAR MEDICINE , cilt.57, 2016 (SCI-Expanded, Scopus)

18. The clinical and biochemical presentation of vitamin D deficiency and insufficiency in children and adolescents

Torun E., Genc H., Gonullu E., AKOVALI B., Ozgen I. T.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , cilt.26, sa.5-6, ss.469-475, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 6

1. Survival Analysis of Advanced HCC Treated with Yttrium-90 Radioembolization: A 10-year single-center experience

Bilgic S., SAĞER M. S., AKOVALI B., ŞAHİN O. E., Kaymak E., USLU BEŞLİ R. L., et al.
32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 12 - 16 Ekim 2019, cilt.46, (Özet Bildiri) Sürdürülebilir Kalkınma

2. Contribution of 68Ga-PSMA-11 PET/CT imaging in Gleason Score 3+3=6 Prostate Cancer

ŞAHİN O. E., Gilgic S., SAĞER M. S., AKOVALI B., AKGÜN E., USLU BEŞLİ R. L., et al.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri)

3. Selective Internal Radiation Therapy (SIRT) for Liver Metastasis of Chemoresistant Breast Cancer: Overall Survival and Dose - Response Relationship

AKOVALI B., Akgun E. K., ŞAHİN O. E., YEYİN N., Abuqbeitah M., Tanyildizi H., et al.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri)

4. 68Ga-DOTA-TATE PET-CT in differentiated thyroid cancer patients: comparison with 18F-FDG PET-CT

Vatankulu B., AKOVALI B., SAĞER M. S., Halac M., KABASAKAL L., SÖNMEZOĞLU K.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 15 - 19 Ekim 2016, cilt.43, (Özet Bildiri) Sürdürülebilir Kalkınma

5. Normal Distribution Pattern and Physiological Variants of Ga-68-PSMA PET/CT

Demirci E., ŞAHİN O. E., Ocak M., AKOVALI B., Nematyazar J., KABASAKAL L.
Annual Congress of the European-Association-of-Nuclear-Medicine, Barcelona, İspanya, 15 - 19 Ekim 2016, cilt.43, (Özet Bildiri)

6. CINCA syndrome in an infant presenting with hydrocephalus

Turel O., Uzunel S., Keskin O., AKOVALI B., ERENBERK U., Tatli B.
European Congress of Immunology, Glasgow, İngiltere, 5 - 08 Eylül 2012, cilt.137, ss.524, (Özet Bildiri)
Metrikler

Yayın

24

Yayın (WoS)

24

Yayın (Scopus)

17

Atıf (WoS)

176

H-İndeks (WoS)

5

Atıf (Scopus)

190

H-İndeks (Scopus)

4

Atıf (Scholar)

284

H-İndeks (Scholar)

5

Açık Erişim

4
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER
SDG 5: AMAÇ 5: CİNSİYET EŞİTLİĞİ